The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Oynotkinova O.Sh.
Research Institute of Health Organization and Medical Management;
Central State Medical Academy of the Office of the President of the Russian Federation
Maslennikova O.M.
Central State Medical Academy of the Office of the President of the Russian Federation
Pavlov A.I.
National Medical Research Center for High Medical Technologies — Vishnevsky Central Military Clinical Hospital
Acetylsalicylic acid in primary and secondary prevention of atherosclerotic cardiovascular disease
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5): 58‑64
Read: 2660 times
To cite this article:
Oynotkinova OSh, Matskeplishvili ST, Maslennikova OM, Pavlov AI, Poberezhskaya AG. Acetylsalicylic acid in primary and secondary prevention of atherosclerotic cardiovascular disease. S.S. Korsakov Journal of Neurology and Psychiatry.
2023;123(5):58‑64. (In Russ.)
https://doi.org/10.17116/jnevro202312305158
The article is devoted to an urgent problem — primary and secondary prevention of atherosclerotic cardiovascular diseases. Modern approaches to management tactics depending on age and the appointment of antiplatelet therapy with acetylsalicylic acid in low doses from 75 to 150 mg/day are presented. At the same time, the relatively high effectiveness of the use of ASA for primary prevention in men 40-69 years old without an increased risk of bleeding from the gastrointestinal tract is shown. Low doses of ASA provide little benefit in reducing the risk of CVD in people 40 years and older, when there is no history of CVD, but at the same time they are at increased risk of CVD.
Keywords:
Authors:
Oynotkinova O.Sh.
Research Institute of Health Organization and Medical Management;
Central State Medical Academy of the Office of the President of the Russian Federation
Maslennikova O.M.
Central State Medical Academy of the Office of the President of the Russian Federation
Pavlov A.I.
National Medical Research Center for High Medical Technologies — Vishnevsky Central Military Clinical Hospital
Received:
18.04.2023
Accepted:
22.05.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.